Not applicableStudy completedNCT02622477
What this trial is testing
Clinical Progression of Mild to Moderate Idiopathic Pulmonary Fibrosis (IPF) Under a Therapy With Esbriet® (Pirfenidone)
Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 12